Collier Neurologic Specialists

Naples, Florida 34105

0 studies enrolling now · 20 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Brain Infarction, Central Neuropathic Pain, Cerebral Ischemia, Lewy Body Dementia, Low Back Pain, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Parkinson's Disease, Parkinson's Disease Dementia, Spasticity With Multiple Sclerosis

Studies at this site

• Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis — Running, not enrolling
• A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) — Running, not enrolling
• Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis — Stopped early
• A Study of Semorinemab in Patients With Moderate Alzheimer's Disease — Completed
• Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis — Status unconfirmed
• SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study — Completed
• A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease — Paused
• A Study to Evaluate the Efficacy and Safety of Semorinemab in Patients With Prodromal to Mild Alzheimer's Disease — Stopped early
• Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis — Completed
• A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB) — Completed
• RN624 In Adult Patients With Chronic Low Back Pain — Completed
• A Study of Tanezumab in Adults With Chronic Low Back Pain — Completed
• Long Term Safety Study of Tanezumab in Chronic Low Back Pain — Stopped early
• A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab — Completed
• Observational Registry of Acthar Gel for Participants With Multiple Sclerosis Relapse — Completed
• A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease — Completed
• A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY) — Completed
• Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD) — Completed
• EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD) — Completed
• ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke — Stopped early